Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

1.

Aspirin: new cardiovascular uses for an old drug.

Patrono C.

Am J Med. 2001 Jan 8;110(1A):62S-65S. Review.

PMID:
11166001
2.

[A 100 years of aspirin: a drug with a future?].

Sánchez García P.

An R Acad Nac Med (Madr). 1997;114(1):157-63; discussion 164-7. Spanish. No abstract available.

PMID:
9324911
3.

Current perspective on the cardiovascular effects of coxibs.

Konstam MA, Weir MR.

Cleve Clin J Med. 2002;69 Suppl 1:SI47-52. Review.

PMID:
12086293
5.

Aspirin in cardiovascular disorders. What is the optimum dose?

Kong DF.

Am J Cardiovasc Drugs. 2004;4(3):151-8. Review.

PMID:
15134467
7.

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.

8.

Efficacy and safety of aspirin in the long-term management of atherothrombosis.

Patrono C.

Haematologica. 2002 Jan;87(1):6-8. No abstract available.

9.

Aspirin revisited: helpful or harmful? What is the correct dose for a certain population?

Drown DJ.

Prog Cardiovasc Nurs. 2008 Winter;23(1):49-50. No abstract available.

PMID:
18326997
10.

Aspirin and cyclooxygenase-2 inhibitors.

Armstrong TA.

Am J Health Syst Pharm. 2003 Jul 15;60(14):1481. No abstract available.

PMID:
12892035
11.

Aspirin therapy for cardiovascular disease.

Goodnight SH.

Curr Opin Hematol. 1996 Sep;3(5):355-60. Review.

PMID:
9372101
12.
13.
14.

High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs--pharmacological mechanisms and clinical relevance.

Hohlfeld T, Saxena A, Schrör K.

Thromb Haemost. 2013 May;109(5):825-33. doi: 10.1160/TH12-07-0532. Epub 2012 Dec 13. Review.

PMID:
23238666
15.

Strategies to reduce the GI risks of antiplatelet therapy.

Scheiman JM.

Rev Cardiovasc Med. 2005;6 Suppl 4:S23-31. Review.

PMID:
17710073
16.

[Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].

Morini S, Zullo A.

G Ital Cardiol (Rome). 2010 Jun;11(6):488-92; discussion 492. Italian. No abstract available.

PMID:
20922875
17.

Aspirin: old drug, new uses and challenges.

Yeomans ND.

J Gastroenterol Hepatol. 2011 Mar;26(3):426-31. doi: 10.1111/j.1440-1746.2010.06569.x.

PMID:
21062358
18.

Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?

Savage R.

Drugs Aging. 2005;22(3):185-200. Review.

PMID:
15813652
19.

New guidelines refine aspirin prescription. Task force offers recommendation for women and guidance on dosage.

[No authors listed]

Harv Heart Lett. 2009 Jun;19(10):4-5. No abstract available.

PMID:
19681207
20.

Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.

Weir MR, Sperling RS, Reicin A, Gertz BJ.

Am Heart J. 2003 Oct;146(4):591-604. Review.

PMID:
14564311

Supplemental Content

Support Center